BioPharmCatalyst

BioPharmCalalyst's drug and regulatory approval tracker is meant to minimize information asymmetry, the website's founder told Benzinga. How The Platform Started  Adam Burden, an international business graduate from the University of Sydney, told Benzinga he became interested in...

Biotech stocks are regaining some lost momentum after Wednesday's Trump-inspired selloff that took a toll on the sentiment on pharma sector. The weakness was so stark that it made CNBC's Brian Sullivan tweet that biotechs/healthcare was the only sector to have been left out of what seemed...